ResMed | RMD - Assets



ResMed reported $8.17B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Ansell USD 3.24B 717.4M Jun/2024
AtriCure USD 608.85M 17.22M Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Cochlear AUD 2.79B 41M Dec/2024
Cooper Companies USD 12.38B 36.9M Jul/2025
CSL USD 38.45B 425M Dec/2024
Dexcom USD 7.33B 575.3M Jun/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
Fisher Paykel Healthcare NZD 2.55B 115.4M Mar/2025
Globus Medical USD 4.96B 249.94M Jun/2025
Haemonetics USD 2.46B 11.15M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Idexx Laboratories USD 3.33B 117.1M Jun/2025
Insulet USD 3.47B 48.1M Jun/2025
Integra LifeSciences USD 3.67B 384.85M Jun/2025
Intuitive Surgical USD 20.16B 942.8M Jun/2025
Masimo USD 2.4B 109.5M Jun/2025
Medtronic USD 91.68B 1.71B Apr/2025
Philips EUR 26.38B 788M Jun/2025
Ramsay Health Care AUD 20.66B 237M Dec/2024
ResMed USD 8.17B 607.57M Jun/2025
Sigma Healthcare AUD 1.7B 324.84M Jul/2024
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Steris USD 10.4B 258.19M Jun/2025
Teleflex USD 7.38B 211.93M Jun/2025
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025